1h Free Analyst Time
The publisher has been monitoring the anorexiants market and it is poised to grow by $1.05 bn during 2022-2026 progressing at a CAGR of 4.62% during the forecast period. The report on the anorexiants market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing obese population, increasing government initiatives for healthcare infrastructure, and vendors strategies such as mergers and acquisition (M and A) activities.
The anorexiants market analysis includes the distribution channel segment and geographic landscape.
The anorexiants market is segmented as below:
By Distribution Channel
- Hospital pharmacy
- Retail pharmacy
- Online pharmacy
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the research and approval of new drugs as one of the prime reasons driving the anorexiants market growth during the next few years. Also, awareness about weight management and increase in childhood obesity and morbid obesity incidence will lead to sizable demand in the market.
The report on anorexiants market covers the following areas:
- Anorexiants market sizing
- Anorexiants market forecast
- Anorexiants market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading anorexiants market vendors that include Arena Pharmaceuticals Inc., Bausch Health Companies Inc., Currax Pharmaceuticals LLC, Elite Pharmaceuticals Inc., Epic Pharma LLC, F. Hoffmann La Roche Ltd., Hi Tech Pharmaceuticals, Johnson and Johnson, KVK Tech Inc., Lannett Co. Inc., Novartis AG, Novo Nordisk AS, Nuvo Pharmaceuticals Inc., Pfizer Inc., Recordati SpA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Virtus Nutrition LLC., VIVUS LLC, and Zydus Lifesciences Ltd. Also, the anorexiants market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2. Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3. Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4. Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5. Market Segmentation by Distribution Channel
5.1 Market segments
Exhibit 24: Chart on Distribution Channel - Market share 2021-2026 (%)
Exhibit 25: Data Table on Distribution Channel - Market share 2021-2026 (%)
5.2 Comparison by Distribution Channel
Exhibit 26: Chart on Comparison by Distribution Channel
Exhibit 27: Data Table on Comparison by Distribution Channel
5.3 Hospital pharmacy - Market size and forecast 2021-2026
Exhibit 28: Chart on Hospital pharmacy - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Hospital pharmacy - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Hospital pharmacy - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Hospital pharmacy - Year-over-year growth 2021-2026 (%)
5.4 Retail pharmacy - Market size and forecast 2021-2026
Exhibit 32: Chart on Retail pharmacy - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Retail pharmacy - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Retail pharmacy - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Retail pharmacy - Year-over-year growth 2021-2026 (%)
5.5 Online pharmacy - Market size and forecast 2021-2026
Exhibit 36: Chart on Online pharmacy - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Online pharmacy - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Online pharmacy - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Online pharmacy - Year-over-year growth 2021-2026 (%)
5.6 Market opportunity by Distribution Channel
Exhibit 40: Market opportunity by Distribution Channel ($ million)
6. Customer Landscape
6.1 Customer landscape overview
Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7. Geographic Landscape
7.1 Geographic segmentation
Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 44: Chart on Geographic comparison
Exhibit 45: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Canada - Market size and forecast 2021-2026
Exhibit 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.9 UK - Market size and forecast 2021-2026
Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.10 Germany - Market size and forecast 2021-2026
Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.11 Japan - Market size and forecast 2021-2026
Exhibit 78: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on Japan - Year-over-year growth 2021-2026 (%)
7.12 China - Market size and forecast 2021-2026
Exhibit 82: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 83: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 84: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 85: Data Table on China - Year-over-year growth 2021-2026 (%)
7.13 Market opportunity By Geographical Landscape
Exhibit 86: Market opportunity By Geographical Landscape ($ million)
8. Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 87: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9. Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 89: Overview on factors of disruption
9.4 Industry risks
Exhibit 90: Impact of key risks on business
10. Vendor Analysis
10.1 Vendors covered
Exhibit 91: Vendors covered
10.2 Market positioning of vendors
Exhibit 92: Matrix on vendor position and classification
10.3 Arena Pharmaceuticals Inc.
Exhibit 93: Arena Pharmaceuticals Inc. - Overview
Exhibit 94: Arena Pharmaceuticals Inc. - Product / Service
Exhibit 95: Arena Pharmaceuticals Inc. - Key offerings
10.4 Epic Pharma LLC
Exhibit 96: Epic Pharma LLC - Overview
Exhibit 97: Epic Pharma LLC - Product / Service
Exhibit 98: Epic Pharma LLC - Key offerings
10.5 F. Hoffmann La Roche Ltd.
Exhibit 99: F. Hoffmann La Roche Ltd. - Overview
Exhibit 100: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 101: F. Hoffmann La Roche Ltd. - Key news
Exhibit 102: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 103: F. Hoffmann La Roche Ltd. - Segment focus
10.6 Johnson and Johnson
Exhibit 104: Johnson and Johnson - Overview
Exhibit 105: Johnson and Johnson - Business segments
Exhibit 106: Johnson and Johnson - Key news
Exhibit 107: Johnson and Johnson - Key offerings
Exhibit 108: Johnson and Johnson - Segment focus
10.7 Lannett Co. Inc.
Exhibit 109: Lannett Co. Inc. - Overview
Exhibit 110: Lannett Co. Inc. - Business segments
Exhibit 111: Lannett Co. Inc. - Key news
Exhibit 112: Lannett Co. Inc. - Key offerings
Exhibit 113: Lannett Co. Inc. - Segment focus
10.8 Novo Nordisk AS
Exhibit 114: Novo Nordisk AS - Overview
Exhibit 115: Novo Nordisk AS - Business segments
Exhibit 116: Novo Nordisk AS - Key offerings
Exhibit 117: Novo Nordisk AS - Segment focus
10.9 Pfizer Inc.
Exhibit 118: Pfizer Inc. - Overview
Exhibit 119: Pfizer Inc. - Product / Service
Exhibit 120: Pfizer Inc. - Key news
Exhibit 121: Pfizer Inc. - Key offerings
10.10 Recordati SpA
Exhibit 122: Recordati SpA - Overview
Exhibit 123: Recordati SpA - Business segments
Exhibit 124: Recordati SpA - Key offerings
Exhibit 125: Recordati SpA - Segment focus
10.11 Teva Pharmaceutical Industries Ltd.
Exhibit 126: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 127: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 128: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 129: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 130: Teva Pharmaceutical Industries Ltd. - Segment focus
10.12 VIVUS LLC
Exhibit 131: VIVUS LLC - Overview
Exhibit 132: VIVUS LLC - Business segments
Exhibit 133: VIVUS LLC - Key news
Exhibit 134: VIVUS LLC - Key offerings
Exhibit 135: VIVUS LLC - Segment focus
11. Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 136: Inclusions checklist
Exhibit 137: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 138: Currency conversion rates for US$
11.4 Research methodology
Exhibit 139: Research methodology
Exhibit 140: Validation techniques employed for market sizing
Exhibit 141: Information sources
11.5 List of abbreviations
Exhibit 142: List of abbreviations
List of ExhibitsExhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Vendor Market Positioning
Exhibits 9: Parent market
Exhibits 10: Market Characteristics
Exhibits 11: Offerings of vendors included in the market definition
Exhibits 12: Market segments
Exhibits 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 17: Five forces analysis - Comparison between2021 and 2026
Exhibits 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits 20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits 21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits 22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits 23: Chart on Market condition - Five forces 2021 and 2026
Exhibits 24: Chart on Distribution Channel - Market share 2021-2026 (%)
Exhibits 25: Data Table on Distribution Channel - Market share 2021-2026 (%)
Exhibits 26: Chart on Comparison by Distribution Channel
Exhibits 27: Data Table on Comparison by Distribution Channel
Exhibits 28: Chart on Hospital pharmacy - Market size and forecast 2021-2026 ($ million)
Exhibits 29: Data Table on Hospital pharmacy - Market size and forecast 2021-2026 ($ million)
Exhibits 30: Chart on Hospital pharmacy - Year-over-year growth 2021-2026 (%)
Exhibits 31: Data Table on Hospital pharmacy - Year-over-year growth 2021-2026 (%)
Exhibits 32: Chart on Retail pharmacy - Market size and forecast 2021-2026 ($ million)
Exhibits 33: Data Table on Retail pharmacy - Market size and forecast 2021-2026 ($ million)
Exhibits 34: Chart on Retail pharmacy - Year-over-year growth 2021-2026 (%)
Exhibits 35: Data Table on Retail pharmacy - Year-over-year growth 2021-2026 (%)
Exhibits 36: Chart on Online pharmacy - Market size and forecast 2021-2026 ($ million)
Exhibits 37: Data Table on Online pharmacy - Market size and forecast 2021-2026 ($ million)
Exhibits 38: Chart on Online pharmacy - Year-over-year growth 2021-2026 (%)
Exhibits 39: Data Table on Online pharmacy - Year-over-year growth 2021-2026 (%)
Exhibits 40: Market opportunity by Distribution Channel ($ million)
Exhibits 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 44: Chart on Geographic comparison
Exhibits 45: Data Table on Geographic comparison
Exhibits 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits 65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 78: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits 79: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits 80: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibits 81: Data Table on Japan - Year-over-year growth 2021-2026 (%)
Exhibits 82: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits 83: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits 84: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits 85: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits 86: Market opportunity By Geographical Landscape ($ million)
Exhibits 87: Impact of drivers and challenges in 2021 and 2026
Exhibits 88: Overview on Criticality of inputs and Factors of differentiation
Exhibits 89: Overview on factors of disruption
Exhibits 90: Impact of key risks on business
Exhibits 91: Vendors covered
Exhibits 92: Matrix on vendor position and classification
Exhibits 93: Arena Pharmaceuticals Inc. - Overview
Exhibits 94: Arena Pharmaceuticals Inc. - Product / Service
Exhibits 95: Arena Pharmaceuticals Inc. - Key offerings
Exhibits 96: Epic Pharma LLC - Overview
Exhibits 97: Epic Pharma LLC - Product / Service
Exhibits 98: Epic Pharma LLC - Key offerings
Exhibits 99: F. Hoffmann La Roche Ltd. - Overview
Exhibits 100: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 101: F. Hoffmann La Roche Ltd. - Key news
Exhibits 102: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 103: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 104: Johnson and Johnson - Overview
Exhibits 105: Johnson and Johnson - Business segments
Exhibits 106: Johnson and Johnson - Key news
Exhibits 107: Johnson and Johnson - Key offerings
Exhibits 108: Johnson and Johnson - Segment focus
Exhibits 109: Lannett Co. Inc. - Overview
Exhibits 110: Lannett Co. Inc. - Business segments
Exhibits 111: Lannett Co. Inc. - Key news
Exhibits 112: Lannett Co. Inc. - Key offerings
Exhibits 113: Lannett Co. Inc. - Segment focus
Exhibits 114: Novo Nordisk AS - Overview
Exhibits 115: Novo Nordisk AS - Business segments
Exhibits 116: Novo Nordisk AS - Key offerings
Exhibits 117: Novo Nordisk AS - Segment focus
Exhibits 118: Pfizer Inc. - Overview
Exhibits 119: Pfizer Inc. - Product / Service
Exhibits 120: Pfizer Inc. - Key news
Exhibits 121: Pfizer Inc. - Key offerings
Exhibits 122: Recordati SpA - Overview
Exhibits 123: Recordati SpA - Business segments
Exhibits 124: Recordati SpA - Key offerings
Exhibits 125: Recordati SpA - Segment focus
Exhibits 126: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits 127: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits 128: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits 129: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits 130: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits 131: VIVUS LLC - Overview
Exhibits 132: VIVUS LLC - Business segments
Exhibits 133: VIVUS LLC - Key news
Exhibits 134: VIVUS LLC - Key offerings
Exhibits 135: VIVUS LLC - Segment focus
Exhibits 136: Inclusions checklist
Exhibits 137: Exclusions checklist
Exhibits 138: Currency conversion rates for US$
Exhibits 139: Research methodology
Exhibits 140: Validation techniques employed for market sizing
Exhibits 141: Information sources
Exhibits 142: List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global anorexiants market: Arena Pharmaceuticals Inc., Bausch Health Companies Inc., Currax Pharmaceuticals LLC, Elite Pharmaceuticals Inc., Epic Pharma LLC, F. Hoffmann La Roche Ltd., Hi Tech Pharmaceuticals, Johnson and Johnson, KVK Tech Inc., Lannett Co. Inc., Novartis AG, Novo Nordisk AS, Nuvo Pharmaceuticals Inc., Pfizer Inc., Recordati SpA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Virtus Nutrition LLC., VIVUS LLC, and Zydus Lifesciences Ltd..Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is research and approval of new drugs.`
According to the report, one of the major drivers for this market is the growing obese population.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Arena Pharmaceuticals Inc.
- Bausch Health Companies Inc.
- Currax Pharmaceuticals LLC
- Elite Pharmaceuticals Inc.
- Epic Pharma LLC
- F. Hoffmann La Roche Ltd.
- Hi Tech Pharmaceuticals
- Johnson and Johnson
- KVK Tech Inc.
- Lannett Co. Inc.
- Novartis AG
- Novo Nordisk AS
- Nuvo Pharmaceuticals Inc.
- Pfizer Inc.
- Recordati SpA
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Virtus Nutrition LLC.
- VIVUS LLC
- Zydus Lifesciences Ltd.
